Sirt1 Inhibits Akt2-Mediated Porcine Adipogenesis Potentially by Direct Protein-Protein Interaction

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Pang, Weijun ^a   Wang, Yu ^a   Wei, Ning ^a   Xu, Ruxiang ^a   Xiong, Yan ^a   Wang, Ping ^a   Shen, Qingwu ^a   Yang, Gongshe ^a  

^a NORTHWEST A F UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE B BETA; SIRTUIN 1;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREED DIFFERENCE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; LIPOGENESIS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SWINE;

ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE KNOCKOUT TECHNIQUES; INSULIN; LIPOGENESIS; MALE; MODELS, BIOLOGICAL; ORGAN SPECIFICITY; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SIRTUIN 1; SUS SCROFA;

EID: 84881523549     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071576     Document Type: Article

References (57)

1. Gianfranco B, Alfredo C, (2004) Metabolic and cardiovascular disorders in highly inbred lines for intensive pig farming: how animal welfare evaluation could improve the basic knowledge of human obesity. Ann 1st Super Sanita 40: 241-244.
2. Belliger DA, Merrichks EP, Nichols TC, (2006) Swine models of type 2 diabetes mellitus: insulin resistance, glucose tolerance, and cardiovascular complications. ILAR J 47: 243-258.
3. Larsen MO, Rolin B, (2004) Use of the Gottingen minipig as a model of diabetes, with special focus on type 1 diabetes research. ILAR J 45: 303-313.
4. Rosen ED, Spiegelman BM, (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444: 847-853.
5. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, et al. (2003) Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17: 1352-1365.
6. Magun R, Burgering BM, Coffer PJ, Pardasani D, Lin Y, et al. (1996) Expression of a constitutively activated form of protein kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation. Endocrinology 137: 3590-3593.
7. Xu F, Burk D, Gao Z, Yin J, Zhang X, et al. (2012) Angiogenic deficiency and adipose tissue dysfunction are associated with macrophage malfunction in SIRT1-/- mice. Endocrinology 153: 1706-1716.
8. Woodgett JR, (2005) Recent advances in the protein kinase B signaling pathway. Curr Opin Cell Biol 17: 150-157.
9. Dummler B, Hemmings BA, (2007) Physiological roles of PKB/Akt isoforms in development and disease. Biochem Soc Trans 35: 231-235.
10. Altomare DA, Lyons GE, Mitsuuchi Y, Cheng JQ, Testa JR, (1998) Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin. Oncogene 16: 2407-2411.
11. Holst LS, Mulder H, Manganiello V, Sundler F, Ahrén B, et al. (1998) Protein kinase B is expressed in pancreatic beta cells and activated upon stimulation with insulin-like growth factor I. Biochem Biophys Res Commun. 250: 181-186.
12. Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, et al. (2003) Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17: 590-603.
13. Dickson LM, Rhodes CJ, (2004) Pancreatic beta-cell growth and survival in the onset of type 2 diabetes: a role for protein kinase B in the Akt? Am J Physiol Endocrinol Metab 287: E192-E198.
14. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, et al. (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292: 1728-1731.
15. Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, et al. (2003) Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest 112: 197-208.
16. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, et al. (2003) Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17: 1352-1365.
17. Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, et al. (2003) Severe diabetes, age-dependent loss of adipose tissue and mild growth deficiency in mice lacking Akt2/PKBβ. J Clin Invest 112: 197-208.
18. Gillum MP, Erion DM, Shulman GI, (2011) Sirtuin-1 regulation of mammalian metabolism, Trends Mol Med. 17: 8-13.
19. Blander G, Guarente L, (2004) The Sir2 family of protein deacetylases. Annu Rev Biochem 73: 417-435.
20. Xu F, Burk D, Gao Z, Yin J, Zhang X, et al. (2012) Angiogenic deficiency and adipose tissue dysfunction are associated with macrophage malfunction in Sirt1-/- mice. Endocrinology 153: 1706-1716.
21. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, et al. (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429: 771-776.
22. Han L, Zhou R, Niu J, McNutt MA, Wang P, et al. (2010) Sirt1 is regulated by a PPARγ-Sirt1 negative feedback loop associated with senescence. Nucleic Acids Res 38: 7458-7471.
23. Jin Q, Zhang F, Yan T, Liu Z, Wang C, et al. (2010) C/EBPalpha regulates Sirt1 expression during adipogenesis. Cell Res 20: 470-479.
24. Pang WJ, Xiong Y, Wang Y, Tong Q, Yang GS, (2013) Sirt1 attenuates camptothecin-induced apoptosis through Caspase-3 pathway in porcine preadipocytes. Exp Cell Res 319: 670-683.
25. Bai L, Pang WJ, Yang YJ, Yang GS, (2008) Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes. Mol Cell Biochem 307: 129-140.
26. Kadowaki T, Ueki K, Yamauchi T, Kubota N, (2012) SnapShot: Insulin Signaling Pathways. Cell 148: 624-624.
27. Virkamaki A, Ueki K, Kahn CR, (1999) Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103: 931-943.
28. White MF, (2002) IRS proteins and the common path to diabetes. Am J Physiol 283: E413-E422.
29. Corvera S, Czech MP, (1998) Direct targets of phosphoinositide 3-kinase products in membrane traffic and signal transduction. Trends Cell Biol 8: 442-446.
30. Vasudevan KM, Garraway LA, (2010) AKT signaling in physiology and disease. Curr Top Microbiol Immunol 347: 105-133.
31. Yu W, Chen Z, Zhang J, Zhang L, Ke H, et al. (2008) Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells. Mol Cell Biochem 310: 11-18.
32. Hasegawa M, Tang Y, Osawa H, Onuma H, Nishimiya T, et al. (2002) Makino Differential regulation of gene expression and insulin-induced activation of phosphodiesterase 3B in adipocytes of lean insulin-resistant IRS-1 (-/-) mice. Diabetes Res Clin Pract 58: 79-85.
33. Chen D, Mauvais-Jarvis F, Bluher M, Fisher SJ, Jozsi A, et al. (2004) p50alpha/p55alpha phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity. Mol Cell Biol 24: 320-329.
34. Kim SP, Ha JM, Yun SJ, Kim EK, Chung SW, et al. (2010) Transcriptional activation of peroxisome proliferator-activated receptor-gamma requires activation of both protein kinase A and Akt during adipocyte differentiation. Biochem Biophys Res Commun 399: 55-59.
35. Li H, Rajendran GK, Liu N, Ware C, Rubin BP, et al. (2007) Sirt1 modulates the estrogen-insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice. Breast Cancer Res 9: R1.
36. Li Y, Xu W, McBurney MW, Longo VD, (2008) Sirt1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons. Cell Metab 8: 38-48.
37. Fröjdö S, Durand C, Molin L, Carey AL, El-Osta A, et al. (2011) Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by Sirt1. Mol Cell Endocrinol 335: 166-176.
38. Chen S, Xiao X, Feng X, Li W, Zhou N, et al. (2012) Resveratrol induces Sirt1-dependent apoptosis in 3T3-L1 preadipocytes by activating AMPK and suppressing AKT activity and survivin expression. J Nutr Biochem 23: 1100-1112.
39. Fischer-Posovszky P, Tews D, Horenburg S, Debatin KM, Wabitsch M, (2012) Differential function of Akt1 and Akt2 in human adipocytes. Mol Cell Endocrinol 358: 135-143.
40. Gardner S, Anguiano M, Rotwein P (2012) Defining Akt Actions in Muscle Differentiation, Am J Physiol Cell Physiol: in press.
41. Zhang J, Huang K, Shi Z, Zou J, Wang Y, et al. (2011) High β-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression. Neuro Oncol 13: 600-609.
42. Wang Y, Shi X, Qi J, Li X, Uray K, et al. (2012) SIRT1 inhibits the mouse intestinal motility and epithelial proliferation. Am J Physiol Gastrointest Liver Physiol 302: G207-G217.
43. Saunders LR, Sharma AD, Tawney J, Nakagawa M, Okita K, et al. (2010) miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging 7: 415-431.
44. Wang F, Tong Q, (2008) Transcription factor PU.1 is expressed in white adipose and inhibits adipocyte differentiation. Am J Physiol Cell Physiol 295: C213-C220.
45. Conrads KA, Yi M, Simpson KA, Lucas DA, Camalier CE, et al. (2005) A combined proteome and microarray investigation of inorganic phosphate-induced pre-osteoblast cells. Mol Cell Proteomics 4: 1284-1296.
46. Foley NH, Bray IM, Tivnan A, Bryan K, Murphy DM, et al. (2010) MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2. Mol Cancer 9: 83.
47. Li J, Chen Y, Zhao J, Kong F, Zhang Y, (2011) miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Cancer Lett 304: 52-59.
48. Tan SX, Ng Y, Meoli CC, Kumar A, Khoo PS, et al. (2012) Amplification and demultiplexing in insulin-regulated Akt protein kinase pathway in adipocytes. J Biol Chem 287: 6128-6138.
49. Choi Y, Um SJ, Park T (2012) Indole-3-carbinol directly targets SIRT1 to inhibit adipocyte differentiation. Int J Obes: in press.
50. Jin Q, Zhang F, Yan T, Liu Z, Wang C, et al. (2010) C/EBPalpha regulates SIRT1 expression during adipogenesis. Cell Res 20: 470-479.
51. Christoffersen CT, Tornqvist H, Vlahos CJ, Bucchini D, Jami J, et al. (1998) Insulin and insulin-like growth factor-I receptor mediated differentiation of 3T3-F442A cells into adipocytes: effect of PI 3-kinase inhibition. Biochem Biophys Res Commun 246: 426-430.
52. Xia X, Serrero G, (1999) Inhibition of adipose differentiation by phosphatidylinositol 3-kinase inhibitors. J Cell Physiol 178: 9-16.
53. Schultze SM, Jensen J, Hemmings BA, Tschopp O, Niessen M, (2011) Promiscuous affairs of PKB/AKT isoforms in metabolism. Arch Physiol Biochem 117: 70-77.
54. Brazil DP, Yang ZZ, Hemmings BA, (2004) Advances in protein kinase B signaling: AKTion on multiple fronts. Trends Biochem Sci 29: 233-242.
55. Large V, Peroni O, Letexier D, Ray H, Beylot M, (2004) Metabolism of lipids in human white adipocyte. Diabetes Metab 30: 294-309.
56. Isakson P, Hammarstedt A, Gustafson B, Smith U, (2009) Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation. Dabetes 58: 1550-1557.
57. Nakajima I, Muroya S, Chikuni K, (2003) Growth arrest by octanoate is required for porcine preadipocyte differentiation. Biochem Biophys Res Commun 309: 702-708.